Berg TJ - Search Results

1

Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF. Bangstad HJ, et al. Among authors: berg tj. Scand J Clin Lab Invest. 2009;69(1):138-44. doi: 10.1080/00365510802444080. Scand J Clin Lab Invest. 2009. PMID: 18846477

2

[ACE inhibitors and early diabetic nephropathy].

Bangstad HJ, Hartmann A, Berg TJ, Hanssen KF. Bangstad HJ, et al. Among authors: berg tj. Tidsskr Nor Laegeforen. 1995 Oct 10;115(24):3039-41. Tidsskr Nor Laegeforen. 1995. PMID: 7570536 Review. Norwegian.

3

The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study.

Amthor KF, Dahl-Jørgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF. Amthor KF, et al. Among authors: berg tj. Diabetologia. 1994 Jun;37(6):579-84. doi: 10.1007/BF00403376. Diabetologia. 1994. PMID: 7926342 Clinical Trial.

4

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

Berg TJ, Dahl-Jørgensen K, Torjesen PA, Hanssen KF. Berg TJ, et al. Diabetes Care. 1997 Jun;20(6):1006-8. doi: 10.2337/diacare.20.6.1006. Diabetes Care. 1997. PMID: 9167115

5

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.

Berg TJ, Bangstad HJ, Torjesen PA, Osterby R, Bucala R, Hanssen KF. Berg TJ, et al. Metabolism. 1997 Jun;46(6):661-5. doi: 10.1016/s0026-0495(97)90010-x. Metabolism. 1997. PMID: 9186302 Clinical Trial.

6

Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria.

Berg TJ, Nourooz-Zadeh J, Wolff SP, Tritschler HJ, Bangstad HJ, Hanssen KF. Berg TJ, et al. Diabetes Care. 1998 Aug;21(8):1295-300. doi: 10.2337/diacare.21.8.1295. Diabetes Care. 1998. PMID: 9702436 Clinical Trial.

7

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad HJ, Hanssen KF. Berg TJ, et al. Diabetes Care. 1998 Nov;21(11):1997-2002. doi: 10.2337/diacare.21.11.1997. Diabetes Care. 1998. PMID: 9802757

8

Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.

Bangstad HJ, Osterby R, Hartmann A, Berg TJ, Hanssen KF. Bangstad HJ, et al. Among authors: berg tj. Diabetes Care. 1999 Feb;22(2):314-9. doi: 10.2337/diacare.22.2.314. Diabetes Care. 1999. PMID: 10333951

9

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.

Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF. Berg TJ, et al. Diabetes Care. 1999 Jul;22(7):1186-90. doi: 10.2337/diacare.22.7.1186. Diabetes Care. 1999. PMID: 10388987

10

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Kilhovd BK, et al. Among authors: berg tj. Diabetes Care. 1999 Sep;22(9):1543-8. doi: 10.2337/diacare.22.9.1543. Diabetes Care. 1999. PMID: 10480523 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters